<b>Conclusions</b>: We showed that sporadic breast cancer patients with a lower incidence of recurrence demonstrate a higher level of BRCA1 gene methylation after 5 years of follow-up, suggesting its role as a predictive biomarker. The gene discussed is BRCA1; the disease is breast carcinoma.